Analysts expect BridgeBio Pharma, Inc. to report revenue of 332.33 M for Q4 26, against a range of 319.28 M to 345.39 M. The most recent reported quarter, Q3 26, came in at 353.17 M, a 23.6% beat against the 285.62 M consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 5.88 M | 116.63 M | 110.56 M | 120.70 M | 154.18 M | 194.51 M | 243.68 M | 353.17 M | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 3.07 M | 65.53 M | 89.46 M | 109.01 M | 151.50 M | 192.41 M | 247.50 M | 312.15 M | 345.39 M | 374.23 M | 381.69 M | 449.32 M | 960.31 M | 791.71 M | 498.23 M | 398.78 M | |||||||||
| Low Estimate | 2.77 M | 60.99 M | 82.17 M | 97.93 M | 134.17 M | 172.25 M | 213.01 M | 259.09 M | 319.28 M | 334.17 M | 353.34 M | 392.21 M | 822.52 M | 682.61 M | 451.28 M | 350.09 M | |||||||||
| Consensus Estimate | 2.92 M | 63.26 M | 85.81 M | 103.47 M | 142.83 M | 182.33 M | 230.26 M | 285.62 M | 332.33 M | 354.20 M | 367.51 M | 420.77 M | 891.41 M | 737.16 M | 474.75 M | 374.44 M |
Analysts expect BridgeBio Pharma, Inc. to report earnings per share of -0.61 for Q4 26, against a range of -0.64 to -0.58. The most recent reported quarter, Q3 26, came in at -0.42, a 25.0% beat against the -0.56 consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -1.40 | -0.88 | -0.95 | -0.95 | -1.00 | -0.84 | -0.78 | -0.42 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | -1.12 | -0.78 | -0.69 | -0.81 | -0.64 | -0.67 | -0.55 | -0.54 | -0.58 | -0.47 | -0.32 | -0.16 | -0.18 | 0.56 | 0.75 | 1.06 | |||||||||
| Low Estimate | -1.26 | -0.94 | -0.79 | -0.89 | -0.70 | -0.75 | -0.65 | -0.58 | -0.64 | -0.53 | -0.36 | -0.20 | -0.20 | 0.52 | 0.67 | 0.98 | |||||||||
| Consensus Estimate | -1.19 | -0.86 | -0.74 | -0.85 | -0.67 | -0.71 | -0.60 | -0.56 | -0.61 | -0.50 | -0.34 | -0.18 | -0.19 | 0.54 | 0.71 | 1.02 |
Pull Wall Street consensus for BridgeBio Pharma, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=BBIO&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "BBIO", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=BBIO&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();